Histone deacetylase inhibitors in psoriasis therapy

Current Drug Targets: Inflammation and Allergy

Volumn 3, Issue 2, 2004, Pages 213-219

  Mclaughlin, Fiona ^a   La Thangue, Nicholas B ^b  

^a BioAlliance Pharma   (France)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Angiogenesis; Cell cycle; Chromatin; Histone deacetylase; Keratinocyte; Proliferation; Psoriasis

Indexed keywords

3 PHENYLSULFAMOYLCINNAMOHYDROXAMIC ACID; 4 [N (2 HYDROXYETHYL) N [2 (3 INDOLYL)ETHYL]AMINOMETHYL]CINNAMOHYDROXAMIC ACID; 4 N ACETYLDINALINE; ALPHA TUBULIN; ANTIPSORIASIS AGENT; BETA CATENIN; BUTYRIC ACID; CELL NUCLEUS DNA; CYTOKINE; DEPSIPEPTIDE; HEAT SHOCK PROTEIN 60; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; KARYOPHERIN ALPHA; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; PDX 101; PIVALOYLOXYMETHYL BUTYRATE; PROTEIN BCL 6; PROTEIN P50; PROTEIN P53; PYROXAMIDE; RETINOBLASTOMA PROTEIN; SULFONAMIDE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VORINOSTAT;

ACETYLATION; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; KERATINOCYTE; NEUTROPENIA; NONHUMAN; PROTEIN DEGRADATION; PSORIASIS VULGARIS; REVIEW; STRUCTURE ACTIVITY RELATION; THROMBOCYTOPENIA;

ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; PSORIASIS;

EID: 3042589547     PISSN: 1568010X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568010043343859     Document Type: Review

References (49)

1. Henseler, T.; Christophers, E. J. Am. Acad. Dermatol., 1985, 13, 340.
2. Christophers, E.; Henseler, T. In Psoriasis, Roenigk, H.H.; Maibach, H.I., Ed.; Marcel Dekker: New York, 1990; 2nd Edn., 15-21.
3. Mitchel, J.C. Can. Med. Assoc. J., 1967, 97, 1346.
4. Kenney, J. In Psoriasis: Proceedings of an International Symposium on Psoriasis, Faber E.M., Cox A.J., Eds.; Stanford University Press: Stanford, CA, 1971, 45-51.
5. Farber, E.M.; Nall, M.L. In Psoriasis, Roenigk, H.H.; Maibach, H.I., Ed.; Marcel Dekker: New York, 1998, 3rd Edn., 107-158.
6. Christophers, E. Clinical Dermatology, 2001, 26, 314.
7. Van Scott, E.J.; Ekel, T.M. Arch. Dermatol., 1963, 88, 373.
8. Bata-Csorgo, Z.; Hammerber, C.; Voorhees, J.J.; Cooper, K.D. J. Clin. Invest., 1995, 95, 317.
9. Bos, J.D.; Hulsebosch, H.J.; Krieg, S.R.; Bakker, P.M.; Cormane, R.H. Arch. Dermatol. Res., 1983, 275, 181.
10. Ghoreschi, K.; Mrowietz.; Rocken, M. J. Mol. Med., 2003, 81, 471.
11. Mizutani, H.; Ohmoto, Y.; Mizutani, T.; Murata, M.; Shimizu, M. J. Dermatol. Sci., 1997, 14, 145.
12. Telfer, N.R.; Chalmers, R.J.; Whale, K.; Colman, G. Arch. Dermatol., 1992, 128, 39.
13. Obuch, M.L.; Maurer, T.A., Becker, B.; Berger, T.G. J. Am. Acad. Dermatol., 1992, 128, 667.
14. Fischle, W.; Wang, Y.; Allis, C.D. Curr. Opin. Cell Biol., 2003, 15, 172.
15. Kouzarides, T. Curr. Opin. Genet. Dev., 1999, 9, 40.
16. Spencer, V.A.; Davie, J.R. Gene, 1999, 240, 1.
17. Schreiber, S.L.; Bernstein, B.E. Cell, 2002, 111, 771.
18. Marmorstein, R. Cell Mol. Life Sci., 2001, 58, 693.
19. Melcher, M.; Schmid, M.; Aaagaard, L.; Selenko, P.; Laible, G.; Jenuwein, T. Mol. Cell Biol., 2000, 20, 3728.
20. Kouzarides, T. EMBO J., 2000, 19, 1176.
21. Martinez-Balbas, M.A.; Bauer, U.-M.; Nielsen, S.J.; Brehm, A.; Kouzarides, T. EMBO J., 2000, 19, 662.
22. Rundlett, S.E.; Carmen, A.A.; Kobayashi, R.; Bavykin, S.; Turner, B.M.; Grunstein, M. Proc. Natl. Acad. Sci. USA, 1996, 10, 14503.
23. Tanner, K.G.; Landry, J.; Sternglanz, R.; Denu, J.M. Proc. Natl. Acad. Sci. USA, 2000, 97, 14178.
24. Imai, S.; Armstrong, C.M.; Kaeberlein, M.; Guarente, L. Nature, 2000, 403, 795.
25. Cheng, H.L.; Mostoslavsky, R.; Saito, S.; Manis, J.P.; Gu, Y.; Patel, P.; Bronson, R.; Appella, E.; Alt, F.W.; Chua, K.F. Proc. Natl. Acad. Sci. USA, 2003, 100, 10794.
26. Yoshida, M.; Kijima, M.; Akita, M.; Beppu, T. J. Biol. Chem., 1990, 28, 17174.
27. Vigushin, D.M.; Ali, S.; Pace, P.E.; Mirsaidi, N.; Ito, K.; Adcock, I.; Coombes, R.C. Clin. Cancer Res., 2001, 7, 971.
28. Kim, Y.B.; Ki, S.W.; Yoshida, M.; Horinouchi, S. J. Antibiot., 2000, 53, 1191.
29. Finnin, M.S.; Donigian, J.R.; Cohen, A.; Richon, V.M.; Rifkind, R.A.; Marks, P.A.; Breslow, R.; Pavletich, N.P. Nature, 1999, 9, 188.
30. McLaughlin, F.; Finn, P.; La Thangue, N.B. Drug Disc. Today, 2003, 8, 793.
31. Kelly, W.K.; Richon, V.M.; O'Connor, O.; Curley, T.; MacGregor-Curtelli, B.; Tong, W.; Klang, M.; Schwartz, L.; Richardson, S.; Rosa, E.; Drobnjak, M.; Cordon-Cordo, C.; Chiao, J.H.; Rifkind, R.; Marks, P.A.; Scher, H. Clin. Canc. Res., 2003, 1, 3578.
32. Plumb, J.A.; Finn, P.W.; Williams, R.J.; Bandara, M.J.; Romero, M.R.; Watkins, C.J.; La Thangue, N.B.; Brown, B. Mol. Cancer Therapeutics, 2003, 2, 721.
33. Bouchain, G.; Leit, S.; Frechette, S.; Khalil, E.A.; Lavoie, R.; Moradei, O.; Woo, S.H.; Fournel, M.; Yan, P.T.; Kalita, A.; Trachy-Bourget, M.C.; Beaulieu, C.; Li, Z.; Robert, M.F.; MacLeod, A.R.; Besterman, J.M.; Delorme, D. J. Med. Chem., 2003, 46, 820.
34. Fournel, M.; Trach-Bourget, M.-C.; Yan, P.T.; Kalita, A.; Bonfils, C.; Beaulieu, C.; Frechette, S.; Leit, S.; Abou-Khalil, E.; Woo, S.-H.; Delorme, D.; MacLeod, R.; Besterman, J.M.; Li, Z. Cancer Res., 2002, 62, 4325.
35. Nemunaitis, J.J.; Orr, D.; Eager, R.; Cunningham, C.C.; Williams, A.; Mennel, R.; Grove, W.; Olson, S. Cancer J., 2003, 9, 58.
36. Furumai, R.; Matsuyama, A.; Kobashi, N.; Lee, K.-H.; Nishiyama, M.; Nakajima, H.; Tanaka, A.; Komatsu, Y.; Nishino, N.; Yoshida, M.; Horinouchi, S. Cancer Res., 2002, 62, 4916.
37. Vigushin, D.M. Curr. Opin. Investig. Drugs, 2002, 3, 1396.
38. Chapman, A.; Keane, P.E.; Meldrum, B.S.; Simiand, J.; Vernieres, J.C. Prog. Neurobiol., 1982, 19, 315.
39. Blaheta, R.A.; Nau, H.; Michaelis, M.; Cinatl, J., Jr. Curr. Medic. Chem., 2002, 9, 1417.
40. Leoni, F.; Zaliani, A.; Bertolini, G.; Porro, G.; Pagani, P.; Pozzi, P.; Dona, G.; Fossati, G.; Sozzani, S.; Azam, T.; Bufler, P.; Fantuzzi, G.; Goncharov, I.; Kim, S.H.; Pomerantz, B.J.; Reznikov, L.L.; Siegmund, B.; Dinarello, C.A.; Mascagni, P. Proc. Natl. Acad. Sci. USA, 2002, 5, 2995.
41. Chung, Y.-L.; Lee, M.-Y.; Wang, A.-J.; Yao, L.-F. Mol. Therapy, 2003, 8, 707.
42. Mishra, N.; Brown, D.R.; Olorenshaw, I.M.; Kammer, G.M. Proc. Natl. Acad. Sci. USA, 2001, 98, 2628.
43. Ito, K.; Lim, S.; Caramori, G.; Cosio, B.; Chung, K.F.; Adcock, I.M.; Barnes, P.J. Proc. Natl. Acad. Sci. USA, 2002, 99, 8921.
44. Rosata, R.R.; Grant, S. Cancer Biol. Ther., 2003, 2, 30.
45. Saunders, N.; Kicker, A.; Popa, C.; Jones, S.; Dahler, A. Cancer Research, 1999, 59, 399.
46. He, L.Z.; Tolentino, T.; Grayson, P.; Zhong, S.; Warrell, R.P., Jr.; Rifkind, R.A.; Marks, P.A.; Richon, V.M.; Pandolfi, P.P. J. Clin. Invest., 2001, 108, 1321.
47. Kwon, H.J.; Kim, M.S.; Kim, M.J.; Nakajima, H.; Kim, K.-W. Int. J. Cancer, 2002, 97, 290.
48. Kim, M.S.; Kwon, H.J.; Lee, Y.M.; Baek, J.H.; Jang, J.E.; Lee, S.W.; Moon, E.J.; Kim, H.S.; Lee, S.K.; Chung, H.Y.; Kim, C.W.; Kim, K.W. Nat. Med., 2001, 7, 437.
49. Deroanne, C.F.; Bonjean, K.; Servotte, S.; Devy, L.; Colige, A.; Clausse, N.; Blacher, S.; Verdin, E.; Foidart, J.M.; Nusgens, B.V.; Castronovo, V. Oncogene, 2002, 21, 427.